Navigating the Clinical Research Process for Mild Cognitive Impairment

N/ANot Yet RecruitingNCT06207903

Power Life Sciences Inc.500 enrolled

Overview

Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of mild cognitive impairment patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future mild cognitive impairment patients.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Mild Cognitive Impairment

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed diagnosis of mild cognitive impairment * Participant must be 18 years of age or older * Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study. Exclusion Criteria: * Pregnant or lactating woman * Participant is actively receiving study therapy in another * Inability to provide written informed consent

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a mild cognitive impairment clinical research.

Time frame: 3 months

Number of mild cognitive impairment study participants who remain in clinical study until completion.

Time frame: 12 months